Image

Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation

Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The objective of this study is to assess the functionality of a sensory stimulation device that uses mechanical vibrations and low-intensity electrical currents to deliver proprioceptive feedback to stroke patients regarding their movements.

Eligibility

Inclusion Criteria:

  • For healthy subjects:
    1. No neurological or orthopedic conditions affecting upper limb movement.
    2. No surgical interventions on the upper limbs within the past 6 months.
    3. General physical condition adequate to perform the session.
    4. Cognitive abilities sufficient to understand and carry out the experimental procedure.
  • For stroke survivors:
    1. Ischemic or hemorrhagic stroke resulting in motor impairments in the upper limb.
    2. Chronic stroke condition.
    3. Subjects with sufficient cognitive abilities to follow instructions and actively participate in the therapy.
    4. Mini-Mental State Examination (MMSE) score > 24.
    5. Subjects presenting hemiparesis and mild-to-moderate impairment in the upper limb (score on the Fugl-Meyer Motor Assessment for the upper limb, sections A-D, between 35 and 53 points). The maximum score on the FM scale is 66, with the following severity classifications:
  • 0-15: severe impairment
  • 16-34: moderate-to-severe impairment
  • 35-53: mild-to-moderate impairment
  • 54-66: mild impairment 6. Subjects presenting upper limb hypertonia with a score below 3 on the Modified Ashworth Scale. 7. Subjects who have signed the informed consent document to voluntarily participate in the experiments.

Exclusion Criteria:

  1. Acute musculoskeletal disorders.
  2. Peripheral vascular diseases.
  3. Acute cardiopulmonary conditions.
  4. Acute neurological disorders.
  5. Restricted mobility of upper limb joints due to any cause.
  6. Pain as a cause of impaired upper limb mobility.

Study details
    Healthy Subjects or Volunteers
    Chronic Stroke

NCT07073989

Julio S. Lora Millán

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.